Current Clinical Trials
Reliable Research Inc. is actively enrolling participants in the following studies. If you're interested in joining a trial, please contact us at reliable@research305.com.
Title: myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Type: Interventional
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Status: Recruiting
Summary: Evaluating the effectiveness of high flow nasal therapy in COPD patients using the myAirvo 3 device.
Title: Exploring the Occurrence of Surgical Site Infections
Type: Observational
Condition: Post‑operative infections
Status: Recruiting
Summary: Monitoring infection rates and outcomes following surgical procedures.
Title: Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Irsenontrine)
Type: Interventional
Condition: Dementia with Lewy Bodies
Status: Completed
Summary: Investigating the effects of Irsenontrine on cognitive function and safety in DLB patients.
Title: BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Type: Interventional
Condition: Asthma
Status: Recruiting
Summary: Evaluating the efficacy of combination inhalation therapy in asthma management.
Title: A Randomized, Double‑Blind, 12‑Week (with an Extension to 52 Weeks in a Subset of Participants), Multi‑Center Study to Assess the Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF) Delivered by MDI HFO Compared to BGF Delivered by MDI HFA in Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Type: Interventional Study
Condition: Moderate to Very Severe COPD
Status: Completed
Summary: This study evaluates the safety of BGF (Budesonide, Glycopyrronium, Formoterol Fumarate) delivered via MDI HFO compared to MDI HFA over 12 weeks, with a 52‑week extension for a subset of participants.